A virus that once filled pediatric hospital beds and terrified new parents is finally being pushed back—before babies are ...

The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial ...

For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought welcome ...

A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.

Kennedy Jr. in the country's top health position, use of a long-approved vaccine against measles, mumps, rubella, and ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...

A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from ...

RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

The FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in ...

A senior scientist at the U.S. Centers for Disease Control and Prevention has resigned, warning that changes in leadership ...

The CDC recommends a single dose of RSV vaccine for all adults age 75 and older, as well as for those ages 60 to 74 years at increased risk for severe RSV disease, with three vaccines now approved ...